Found vs CoreAgeRx: Pricing, meds, and program differences
Found vs CoreAgeRx compares two telehealth weight-management options that emphasize medication access but take different approaches. Early verdict: Found positions itself as a biology-first, personalized program with plans starting at as low as $39 and broad insurance handling; CoreAgeRx emphasizes flat, unchanging monthly prices ($79/month for semaglutide, $129/month for tirzepatide) and no membership fees.
Start Found’s biology-first program
How they price treatment: Starting cost and billing model
Pricing is a major contrast. Found advertises getting started for as low as $39 and highlights “Affordable monthly plans” and insurance paperwork handling; marketing also references specific pricing scenarios (for example, $50/mo through Medicare programs) and notes advertised pricing may involve commitments. CoreAgeRx advertises flat monthly pricing with no membership fees and explicit price points: $79/month for semaglutide up to 1.0 mg and $129/month for tirzepatide up to 7.5 mg. CoreAgeRx frames this as “Same Price. Every Month.”
Program model and personalization
Found describes a personalized, medically supervised program built around each person’s metabolic biology, targeting hormones, blood sugar regulation, sleep, and behavioral factors. CoreAgeRx focuses on clinician-reviewed online treatment with short online visits (the landing page references a 3-minute online visit) and consistent monthly pricing. The two differ in emphasis: Found markets a holistic, biology-first approach; CoreAgeRx highlights price predictability and quick online access.
Medication options and regulatory notes
Both providers reference GLP-1 medications and tirzepatide. Found lists tirzepatide and semaglutide and explicitly states availability of compounded GLP-1s while noting compounded medications are not FDA-approved or reviewed by FDA for safety, effectiveness or quality and may not be available in all states. CoreAgeRx lists tirzepatide (any dose up to 7.5 mg) and semaglutide (any dose up to 1.0 mg) and also notes that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Insurance, enrollment and commitments
Found states “Most insurance now accepted,” says it handles insurance paperwork, and references examples like Medicare GLP-1 Bridge Program details and variable coverage, copays, and terms. Found also cautions that Rx is subject to provider review and clinical eligibility and that insurance coverage, pricing and terms vary. CoreAgeRx specifically notes “No insurance required” for enrollment on its landing content, and advises confirming eligibility, medication, total cost, renewal terms and state availability before enrollment because pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Direct comparison table
| Criteria | Found | CoreAgeRx |
|---|---|---|
| Starting price | Get started for as low as $39 | $79/mo semaglutide; $129/mo tirzepatide |
| Pricing model | Affordable monthly plans; insurance handled; references varied offers and commitments | Flat monthly pricing; “Same Price. Every Month.” No membership fee |
| Insurance | Most insurance now accepted; handles paperwork; coverage varies | No insurance required; confirm coverage and terms before enrolling |
| Medications offered | Semaglutide, tirzepatide, branded and compounded options referenced | Semaglutide and tirzepatide (dose caps noted on landing page) |
| Compounded meds | Compounded GLP-1s available; not FDA-approved or evaluated for safety or efficacy | Compounded medications, when offered, are not FDA-approved and not reviewed by FDA |
| Visit/Enrollment | Personalized medical evaluation and program design | 3-minute online visit referenced; clinician review required |
What users can expect from support and transparency
Found emphasizes a medically supervised, whole-body plan focusing on biological factors behind weight. It also displays promotional offer language and specific program details like handling insurance paperwork and references to price examples that depend on commitments and insurance. CoreAgeRx emphasizes no surprises in monthly billing and a simple, consistent price model while recommending users confirm eligibility and state coverage before enrolling.
Explore Found personalized plans
Risks, eligibility and regulatory caveats
Both sources make clear that prescriptions and treatment are subject to clinician review and clinical eligibility. Found explicitly warns that compounded GLP-1s are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality and may not be available in all states. CoreAgeRx includes a similar regulatory caution about compounded products and advises confirming medication-specific approval status.
Compare CoreAgeRx enrollment details
Final thoughts on Found vs CoreAgeRx
Found vs CoreAgeRx boils down to personalization and insurance handling versus price predictability. Found focuses on biology-first, personalized programs with plans starting as low as $39 and promotes handling insurance paperwork. CoreAgeRx emphasizes flat monthly pricing with no membership fee and clear per-medication prices ($79 for semaglutide, $129 for tirzepatide) and short online visits.
Choose Found if you want a biology-based, medically supervised program, broader insurance handling, and plans that advertise getting started for as low as $39. Choose CoreAgeRx if you prioritize predictable flat monthly pricing with no membership fee and the specific advertised price points for semaglutide and tirzepatide.